RptdFinFcst · v5.6 corrected pre-print · sealed snap-1408710-20260817T183438531109Z

FN FQ4-2026 + FY2026 — moonshotai/kimi-k3 CONTRACT PASSED

Fiscal 2026 Q4 and full year (quarter ended June 26, 2026), announced Aug 17 after the close; results unreleased at the cutoff 2026-08-17T14:30:00Z. Three statements, a two-year quarterly path, and a thesis with falsifiable triggers — every identity re-added at intake, the balance sheet rolled from the model's own cash flow.

20tool calls
1contract retries
2anchor retries
0unverified anchors
584swall clock
278filings in corpus

Anchors stated before projecting

Each cites its filing; every anchor value was verified against the cited source at intake.

Q4 FY26 guidance — revenue low ($B, as printed)

1.25

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000016

Q4 FY26 guidance — revenue high ($B, as printed)

1.29

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000016

Q4 FY26 guidance — GAAP diluted EPS low ($)

3.48

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000017

Q4 FY26 guidance — GAAP diluted EPS high ($)

3.63

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000017

Q4 FY26 guidance — non-GAAP diluted EPS low ($)

3.72

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000018

Q4 FY26 guidance — non-GAAP diluted EPS high ($)

3.87

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000018

Q4 FY26 guidance — fully diluted shares basis (M)

36.3

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000017

Q3 FY26 GAAP net income ($M, as printed)

125.2

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000009

Q3 FY26 GAAP diluted EPS ($)

3.45

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000010

Q3 FY26 non-GAAP net income ($M, as printed)

134.9

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000012

Q3 FY26 non-GAAP diluted EPS ($)

3.72

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000013

Q3 FY25 revenue comparative ($M, as printed)

871.8

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000008

Q4 FY26 guidance bridge — SBC EPS adjustment ($)

0.24

0001408710-26-000014 · 0001408710-26-000014:fn-2026504xex991q326.htm:b0000072

Chonburi campus new manufacturing building — construction start year

2,025

0001408710-26-000016 · 0001408710-26-000016:fn-20260327.htm:b0000597

Headline forecast

Revenue ($M) 1,255 p50 1,275 1,295 model guide mid 1,2701,2501,290company
Model p10–p50–p90 against the company's guided range.
Adjusted EPS (USD) 3.66 p50 3.76 3.86 model guide mid 3.793.723.87company
Model p10–p50–p90 against the company's guided range.
Free cash flow ($M) 30 p50 40 60 model
Model p10–p50–p90.

The income statement walk

Prior quarter as filed · forecast · change. ✓ = identity enforced at intake.

Line ($M)Prior as filedForecastΔ
Revenues1,2141,275+5.0%
Cost of revenues1,0701,123+5.0%
Gross profit ✓144152+5.3%
Selling, general and administrative expenses2425+2.9%
Restructuring and other related costs00+0.0%
Operating income ✓120127+5.8%
Interest and other income, net710+28.0%
Foreign exchange gain (loss), net70-100.0%
Other income (expense), net-0-0-5.7%
Income before income taxes ✓134136+1.5%
Income tax expense99-0.3%
Net income ✓125127+1.7%
Weighted average diluted shares3636-0.0%
Diluted EPS (GAAP) ✓3.453.51+1.7%

Bridge: net income 127 + share_based_compensation_cost_of_revenues 3 + share_based_compensation_sga 6 + legal_and_litigation 0 + severance_and_others 0 = non-GAAP net income 136 ÷ 36M shares = 3.76 adjusted EPS.

The cash flow statement

As-reported sign conventions; free cash flow = CFO + capex; ✓ totals re-added at intake.

Line ($M)Prior as filedForecast
Net income125127
Depreciation and amortization1818
Share-based compensation89
Other operating adjustments incl. working capital, net (residual)-99-49
Net cash provided by operating activities ✓53105
Purchases of property, plant and equipment-64-65
Other investing incl. investment purchases/maturities, net (residual)505
Net cash used in investing activities ✓-14-60
Repurchases of ordinary shares-0-2
Other financing incl. debt and taxes on RSUs, net (residual)-1-10
Net cash used in financing activities ✓-1-12
Effect of FX on cash and restricted cash-2-1
Net change in cash and restricted cash (derived total) ✓3732

The projected balance sheet

End of quarter. Cash rolls from the model's own cash flow; retained earnings roll from net income, dividends, and buybacks.

Line ($M)Prior as filedForecast
Cash, cash equivalents and restricted cash357389
All other assets (residual)3,1523,321
Total assets ✓3,5093,710
Total liabilities1,2041,255
Retained earnings2,4272,552
Common stock, paid-in capital and AOCI, net (residual)-122-98
Total shareholders' equity ✓2,3052,455

Expected next-period guidance

Revenue1,300 – 1,350
Adjusted EPS3.85 – 4.00

Quarterly path — where no guide exists

Beyond the guided quarter the model is modeling, not retrieving.

QuarterRev p50 ($M)Rev bandAdj EPS p50GMOMCapexFCF
fiscal 2027 Q1 (ending late September 2026)1,3301,295–1,3653.9712.2%10.2%-6058
fiscal 2027 Q2 (ending late December 2026)1,4051,310–1,5004.2512.3%10.3%-5870
fiscal 2027 Q3 (ending late March 2027)1,4601,360–1,5604.4712.3%10.5%-5585
fiscal 2027 Q4 (ending late June 2027)1,5351,430–1,6404.7612.4%10.6%-52100

Fiscal-year horizons — absolute forecasts, tracked as vintages

Fiscal yearRev p50 ($M)Rev bandAdj EPS p50EPS bandCapexFCF
fiscal year 2026 (ended June 2026 — reported at this release)4,6004,580–4,62013.7513.70–13.80-22681
fiscal year 2027 (ending June 2027)5,7305,350–6,11017.4516.30–18.60-225313
fiscal year 2028 (ending June 2028)6,7006,050–7,35021.2019.30–23.10-240460
fiscal year 2029 (ending June 2029)7,7006,700–8,70025.0022.00–28.00-250640

Thesis — commitments and triggers, all fundamentals

Every commitment cites a source and names the forecast lines it flows into; every trigger is an observable reported fundamental with its check date. Triggers are re-served to the next run for review.

CEO Grady: 'We expect several new customer agreements, particularly in the datacom market, to further strengthen our growth trajectory as we move into the fourth quarter and beyond.'

8-K EX-99.1, 2026-05-04, accession 0001408710-26-000014, block b0000005 · horizon fq4_26 through fy2

flows into: headline.revenue, quarterly_path.fq1_27.revenue, horizons.fy1.revenue, horizons.fy2.revenue

'We began construction of a new manufacturing building at our Chonburi campus in February 2025. We may continue to devote significant resources to the expansion of our manufacturing capacity' — sustained elevated capital intensity to support ramping programs.

10-Q for quarter ended March 27, 2026, accession 0001408710-26-000016, block b0000597 · horizon fy0 through fy3

flows into: cash_flow.capex, horizons.fy1.capex, horizons.fy2.capex, horizons.fy3.capex

High-performance computing products are a distinct, ramping revenue category (HPC revenue of $15.4M / $85.6M / $106.7M in F1Q26-F3Q26 per the Q3 FY26 investor deck), a second AI-driven growth engine alongside optical.

Q3 FY26 investor presentation page 12 (IR-OBSERVED ir:8dd8f0d1f1adf6640d47780ae8374e8b2dad6a8c31a7c3e1fa30bc660940c011); HPC product category defined in 10-Q accession 0001408710-26-000016, block b0000184 · horizon fy1 through fy3

flows into: quarterly_path.fq1_27.revenue, horizons.fy1.revenue, horizons.fy2.revenue, horizons.fy3.revenue

Non-GAAP net income and EPS exclude share-based compensation, severance payment and others, restructuring and other related costs, and legal and litigation costs.

8-K EX-99.1, 2026-05-04, accession 0001408710-26-000014, block b0000030 · horizon all periods

flows into: bridge.non_gaap_net_income, cash_flow.share_based_comp

What would make it a buyer

Datacom + HPC revenue inflects: total revenue ≥ $1.35B in FQ1 FY27 with non-GAAP gross margin ≥ 12.3% (evidence new AI datacom agreements are converting to revenue at accretive margins)

checkable at: FQ1 FY27 earnings 8-K (8-K Item 2.02, expected early November 2026)

Two consecutive quarters of non-GAAP gross margin ≥ 12.5% — a structural margin step-up from the 12.0-12.2% FY26 run-rate

checkable at: FQ2 FY27 earnings 8-K (expected early February 2027)

Quarterly non-GAAP free cash flow ≥ $100M, confirming working-capital normalization after the FY26 inventory build

checkable at: FQ1 FY27 8-K cash flow statement (expected early November 2026)

What would make it a seller

Revenue growth decelerates below 15% year-over-year in any reported quarter (would signal AI optics ramp maturing or share loss)

checkable at: Each quarterly 8-K earnings release, starting FQ1 FY27 (expected early November 2026)

Non-GAAP gross margin below 11.5% for two consecutive quarters (ramp under-absorption or pricing pressure at key customers)

checkable at: FQ2 FY27 earnings 8-K (expected early February 2027), confirming a trend begun in FQ1 FY27

FY27 capex exceeds $350M while FY27 revenue comes in below $5.4B — capacity overbuild versus demand, crushing FCF below ~3% of revenue

checkable at: FY27 Form 10-K (expected mid-August 2027)

Inventories growing more than 10 percentage points faster than revenue for two consecutive quarters (demand forecast miss / customer order pushouts)

checkable at: FQ2 FY27 Form 10-Q (expected early February 2027), following FQ1 FY27 10-Q

What must be true: AI datacenter optics demand keeps compounding: 800G/1.6T transceiver, DCI and HPC programs at Fabrinet's concentrated customer base (Nvidia, Cisco, Lumentum and the new datacom customers management cites) must keep ramping through FY27-29; the Chonburi capacity expansion must come online on schedule to relieve the current capacity constraint; non-GAAP gross margin must hold near 12% despite ramp and new-program drag; and the FY26 working-capital surge (inventories +$297M, receivables +$150M in 9M FY26) must normalize so FCF recovers toward 6-8% of revenue by FY28. If any leg fails — orders pause, margins slip below 11.5%, or inventory keeps outgrowing revenue — the growth and cash-flow paths in this forecast compress quickly given the stock's AI-driven expectations.

Preview note, verbatim

FN reports FQ4 (June) results Monday after the close. Setup: the AI-optics complex is red-hot and FN has beaten the top of its revenue guide three straight quarters (FQ1: $978M vs $940-980M; FQ2: $1,133M vs $1,050-1,100M; FQ3: $1,214M vs $1,150-1,200M). We model $1,275M — the midpoint of the $1.25-1.29B guide — and see bias to the high end given telecom/DCI momentum (DCI +38% q/q in FQ3) and management's commentary on new datacom agreements landing in FQ4. Three things decide the reaction: (1) the revenue print versus $1.29B — another high-end beat keeps the streak alive, but the bar is now high after a 39% y/y FQ3; (2) FQ1 FY27 guidance — anything below ~$1.30B reads as deceleration and will be punished; we expect $1.30-1.35B; (3) margins and cash — non-GAAP GM must hold ~12% while capex (~$65M/qtr) and the inventory build are scrutinized; FQ3 FCF was negative and investors want evidence the working-capital drag is peaking. GAAP EPS print we model at $3.51, non-GAAP at $3.76, both inside the guided ranges ($3.48-3.63 / $3.72-3.87).

Full model reasoning (verbatim)

Anchors are taken from FN's Q3 FY26 8-K EX-99.1 (accession 0001408710-26-000014): Q3 revenue $1,214.3M (39% y/y), GAAP NI $125.2M, GAAP EPS $3.45, non-GAAP NI $134.9M, non-GAAP EPS $3.72; balance sheet at 3/27/26 (total assets $3,509.0M, equity $2,304.7M, cash+restricted $357.3M, zero debt); 9M FY26 CFO $201.8M with capex $160.6M and a $297M inventory build; Q4 FY26 guidance of $1.25-1.29B revenue, GAAP EPS $3.48-3.63, non-GAAP EPS $3.72-3.87 on ~36.3M shares. Method: FN has beaten the top of its revenue guide three consecutive quarters (by $14-58M), and the CEO flagged new datacom agreements strengthening FQ4 and beyond, so my median of $1,275M sits at guidance midpoint with an upward-skewed band (p90 $1,295M, above the guide top; p10 $1,255M, inside the range). Gross margin: GAAP GM has run 11.9-12.2% for five quarters; I model 11.9% GAAP (12.1% non-GAAP) as DCI/HPC mix grows, with slight leverage on a fixed-cost base offset by ramp costs. SG&A grows modestly to $25.0M; restructuring zero. Interest income rises to $9.5M on the higher cash/investment balance; I normalize FX to zero (Q3's +$7.0M gain is volatile) — this is why my GAAP EPS of $3.51 sits low-of-mid in the $3.48-3.63 guided range while tracking the guidance bridge (SBC $0.24/sh) to $3.76 non-GAAP. Tax at ~6.6%, consistent with FY26. Cash flow: revenue +5% q/q forces continued AR/inventory build, so other_operating is -$49M and CFO $105M; capex $65M holds the elevated run-rate (Chonburi build); FCF $40M recovers from FQ3's -$10.8M but stays depressed by working capital. Financing: minimal buybacks, ~$10M RSU withholding taxes. Balance sheet rolls cleanly: cash $389.3M, RE $2,552.4M, equity $2,454.7M, assets $3,710.0M. Path: FY27 revenue $5.73B (+25%) on 800G/1.6T, DCI and HPC ramps, decelerating to +17% (FY28) and +15% (FY29) as the base grows; margins grind up ~10-20bps/yr with scale; capex stays ~4% of revenue then fades; FCF margin recovers to ~8% by FY29. Guidance I expect them to issue for FQ1 FY27: revenue $1.30-1.35B, non-GAAP EPS $3.85-4.00. Key risks to the distribution: customer concentration (top customers' AI capex), FX swings on the Thai baht, and timing of the working-capital unwind.

Sealed as snap-1408710-20260817T183438531109Z over corpus manifest 4678dd1f… (278 filings, five-year window). Replay: python -m rff.filing.snapshot --replay snap-1408710-20260817T183438531109Z. Prompt v5.6. Nothing here is investment advice.